ArticleJournal of translational medicine2025
Exercise-induced hypertrophic preconditioning alleviates myocardial ischemic injury through trained immunity of macrophages.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exercise Metabolic Memory Halts Pathological Cardiac Hypertrophy via PDK4.Circulation research · 2026Article
- Cardiac biomarkers in athletes and active individuals: a clinical review of exercise-induced elevations and diagnostic interpretation.Frontiers in physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundPhysical exercise is known to induce trained immunity and improve function of macrophages, and we recently reported that exercise-induced hypertrophic preconditioning (EHP) could protect pathological hypertrophic heart, but it remains unclear whether EHP can mitigate myocardial ischemic injury. Here we hypothesized that EHP would alleviate acute myocardial ischemic injury through trained immunity of macrophages.
methodsSwimming or treadmill running training was used to induce EHP in C57 mice. After 1-week of exercise termination, mice were subjected to myocardial ischemia/reperfusion (IR). IR injury and inflammatory response and cell energy metabolism reprogramming of bone marrow-derived macrophages (BMDMs) were analysed. Moreover, the effects of exercise on myocardial ischemic injury or long-term survival in patients with acute myocardial infarction (AMI) or history of MI were retrospectively analysed.
resultsEHP mice had a significantly smaller infarct size and less apoptotic cardiomyocytes than IR mice without EHP. At 4 weeks after IR, EHP mice had better cardiac function and less myocardial fibrosis. We noted less infiltration and polarization of myocardial M1 macrophages, higher expression of M2 signature anti-inflammatory factors in BMDMs of EHP mice. EHP promoted tricarboxylic acid cycle, mitochondrial oxidative phosphorylation (OXPHOS) and adenosine 5’-monophosphate activated protein kinase (AMPK) phosphorylation, decreased glycolysis and phosphorylation of AKT and mTOR in BMDMs. Importantly, AMPK inhibitor treatment abrogated the cardioprotective effects of EHP, abolishing the improvement in infarct size and apoptosis and reversing the metabolic reprogramming of macrophages. In mice received treadmill running training for 6 weeks, no physiological hypertrophy occurred but myocardial infarct size after IR was significantly reduced. Similarly, in response to AMI, patients with exercise habit had higher left ventricular ejection fraction and lower plasma levels of cardiac troponin T than those sedentary AMI patients. In 2457 patients with self-reported history of MI, patients with regular exercise habit had significantly lower post-MI mortality.
conclusionsEHP protects heart against myocardial ischemic injury through trained immunity of macrophage mediated by energy metabolism reprogramming.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.